research use only

Milnacipran HCl Serotonin Transporter inhibitor

Cat.No.S3140

Milnacipran inhibits both norepinephrine transporter (NET) and norepinephrine transporter (SERT) with IC50 of 77 nM and 420 nM, respectively.
Milnacipran HCl Serotonin Transporter inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 282.81

Quality Control

Batch: S314001 DMSO]57 mg/mL]false]Water]57 mg/mL]false]Ethanol]57 mg/mL]false Purity: 99.99%
99.99

Chemical Information, Storage & Stability

Molecular Weight 282.81 Formula

C15H22N2O.HCl

Storage (From the date of receipt)
CAS No. 101152-94-7 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl

Solubility

In vitro
Batch:

DMSO : 57 mg/mL ( (201.54 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 57 mg/mL

Ethanol : 57 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
norepinephrine transporter (NET) [1]
77 nM
norepinephrine transporter (SERT) [1]
420 nM
In vitro
Milnacipran is mainly excreted in the urine as the parent and glucoronide (> 80%), and only a small fraction (< 10%) is metabolized via N-de-ethylation by the CYP3A4 enzyme. [1] Milnacipran at high concentration can inhibit certain ligand-gated ion-channel (LGIC) receptors, including NMDA, 5-HT3A and nACh receptors, with IC50 of 58.4 μM, 185 μM, 14.3 μM. [2]
In vivo
Milnacipran (10 and 30 mg/kg, PO) causes a dose-related increase in the extracellular levels of 5-HT and NA in the medial prefrontal cortex of rats. Milnacipran (30 and 60 mg/kg, PO) significantly reduces the duration of both the immobility time in the forced swimming test and the freezing time in the conditioned fear stress test in rats, which are animal behavioral models for depression and anxiety, respectively. [3] Milnacipran (<40 mg/kg i.p.) dose-dependently increases the extracellular levels of NA and 5-HT in hypothalamus of freely moving guinea pigs. Milnacipran administrated at 10 mg/kg and 40 mg/kg decreases NA metabolite MHPG levels by 57% and 47%, respectively, in hypothalamus of freely moving guinea pigs. [4]
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01329406 Unknown status
Osteoarthritis
Analgesic Solutions|Forest Laboratories
July 2011 Phase 4
NCT01328002 Terminated
Primary Fibromyalgia
Forest Laboratories|Cypress Bioscience Inc.
April 30 2011 Phase 2
NCT01418651 Terminated
Fibromyalgia
Banner Health|Forest Laboratories
March 2011 Phase 3
NCT01288807 Completed
Fibromyalgia
University of California San Diego|Forest Laboratories|US Department of Veterans Affairs
February 2011 Phase 4
NCT00725101 Completed
Fibromyalgia
Eli Lilly and Company
June 2008 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.